Clinical Trial Update: Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) [Phase 2]

View source ↗

Summary

Phase 2 safety study of memantine in pediatric patients with autism spectrum disorders, including Asperger syndrome and PDD-NOS, was terminated; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Syndrome
• Autism Spectrum Disorder
• Pervasive Developmental Disorder Not Otherwise Specified

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Forest Laboratories | Conditions: Autism Spectrum Disorder (ASD), Autism | Phase 2 | Status: TERMINATED | Results posted: 2015-02-16